Nov 05, 2020 7:00am EST Sutro Biopharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights and Developments
Sep 09, 2020 4:01pm EDT Sutro Biopharma Presents Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer at the 2020 IGCS Annual Global Meeting
Sep 02, 2020 4:12pm EDT Sutro Biopharma Announces Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer and Presentation at the 2020 IGCS Annual Global Meeting
Aug 25, 2020 7:00am EDT Sutro Biopharma Earns Clinical Supply Milestone Payment from Merck KGaA, Darmstadt, Germany for Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors
Aug 11, 2020 7:00am EDT Sutro Biopharma Announces Two Executive Promotions to Vice President of Quality and Vice President of Manufacturing
Aug 10, 2020 5:00pm EDT Sutro Biopharma to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
Aug 06, 2020 7:00am EDT Sutro Biopharma Reports Second Quarter 2020 Financial Results and Provides Business Highlights and Developments
Jun 22, 2020 7:00am EDT Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity
